Publications by authors named "Daniel Filip"

Claim this Profile
F
FoxO1/Rictor axis induces a nongenetic adaptation to ibrutinib via Akt activation in chronic lymphocytic leukemia.
Laura Ondrisova, Vaclav Seda, Krystof Hlavac, Petra Pavelkova, Eva Hoferkova, Daniel Filip, Filip Vrbacky

J Clin Invest· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drugs.
Eva Hoferkova, Vaclav Seda, Sona Kadakova, Jan Verner, Tomas Loja, Daniel Filip

Leukemia· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tribo-Mechanical Investigation of Glass Fiber Reinforced Polymer Composites under Dry Conditions.
Corina Birleanu, Marius Pustan, Mircea Cioaza, Paul Bere, Glad Contiu, Daniel Filip

Polymers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors.
Sonali Sharma, Gabriela Mladonicka Pavlasova, Vaclav Seda, Katerina Amruz Cerna, Eva Vojackova, Daniel Filip

Blood· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma.
Cosimo Lobello, Boris Tichy, Vojtech Bystry, Lenka Radova, Daniel Filip

Leukemia· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of MYC in the transformation and aggressiveness of 'indolent' B-cell malignancies.
Daniel Filip, Marek Mraz

Leuk Lymphoma· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis